研報掘金丨海通證券:予華勤技術“優於大市”評級,目標價100.88-116.17元
海通證券研報指出,行業景氣持續回暖,AI驅動新一輪創新升級。該行認爲華勤技術(603296.SH)作爲智能硬件ODM龍頭,3+N+3的平臺型模式具備規模效應與成本優勢,立足打造智能手機、筆記本電腦、數據產品爲核心的三個成熟生態組合的基礎上,積極努力拓展汽車電子,軟件業務、機器人三個新的領域和賽道,短期受益行業復甦與AI驅動的行業成長,中長期業務多極拓展空間廣闊,擁有估值溢價。給予公司2025年33-38倍PE估值,對應合理價值區間爲100.88-116.17元/股,給予“優於大市”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.